MARKET

PTHS

PTHS

Pelthos Therapeutics
AMEX
22.67
+0.32
+1.43%
After Hours: 22.23 -0.44 -1.94% 17:12 12/18 EST
OPEN
22.00
PREV CLOSE
22.35
HIGH
22.67
LOW
21.97
VOLUME
14.14K
TURNOVER
--
52 WEEK HIGH
54.29
52 WEEK LOW
5.62
MARKET CAP
69.98M
P/E (TTM)
-1.3264
1D
5D
1M
3M
1Y
5Y
1D
Pelthos Therapeutics Concludes 2025 Annual Stockholder Meeting
TipRanks · 1d ago
Analysts Offer Insights on Healthcare Companies: Novan (NOVN), Pelthos Therapeutics (PTHS) and Scholar Rock Holding (SRRK)
TipRanks · 3d ago
Weekly Report: what happened at PTHS last week (1208-1212)?
Weekly Report · 3d ago
Analysts Offer Insights on Healthcare Companies: Pelthos Therapeutics (PTHS), Insmed (INSM) and IDEAYA Biosciences (IDYA)
TipRanks · 12/08 13:30
Weekly Report: what happened at PTHS last week (1201-1205)?
Weekly Report · 12/08 10:36
Analysts Are Bullish on Top Healthcare Stocks: Pelthos Therapeutics (PTHS), Praxis Precision Medicines (PRAX)
TipRanks · 12/05 14:10
Analysts Are Bullish on These Healthcare Stocks: Pelthos Therapeutics (PTHS), Praxis Precision Medicines (PRAX)
TipRanks · 12/05 14:00
Pelthos signs benefit manager agreement expanding patient access to ZELSUVMI
TipRanks · 12/04 12:05
More
About PTHS
Pelthos Therapeutics Inc. is a biopharmaceutical company focused on commercializing therapeutic products for unmet patient needs. The Company's lead product, ZELSUVMI (berdazimer) topical gel, 10.3%, is used in the treatment of molluscum contagiosum infections (molluscum) in adults and pediatric patients one year of age and older. In addition to ZELSUVMI, the Company has a pipeline of product candidates that utilize its proprietary nitric oxide-based technology platform, NITRICIL. The Company’s product Xepi (ozenoxacin) Cream, 1%, which is a non-fluorinated quinolone antimicrobial indicated for the topical treatment of impetigo. The Company is also evaluating the path forward for its existing NaV 1.7 development programs for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks.

Webull offers Pelthos Therapeutics Inc stock information, including AMEX: PTHS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTHS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PTHS stock methods without spending real money on the virtual paper trading platform.